Has Lee Kaback, MD received payments from drug or device companies?

Yes. Drug and device makers reported $100,469 in general payments to Lee Kaback, MD across 244 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lee Kaback, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lee Kaback, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lee Kaback, MD

Orthopaedic Surgery · Albany, NYNPI 1518976174

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.1%), education and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Catalyst Orthoscience at 35.0% of the total. 2025 is the largest year on record at $23,827, 2.9 times the $8,284 reported in 2019.

$100,469in general payments, 2019–2025

Across 244 payments — averaging $411.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Catalyst Orthoscience$35K
Skeletal Dynamics Inc$29K
Zimmer Biomet$21K
Shoulder Innovations, Inc.$4K
Stryker$4K
Biedermann Motech, Inc.$3K
plus $4K from 11 others

$34,644in ownership & investment interests, 2019–2025

Across 6 payments — averaging $5773.97 each. An ownership or investment interest held by the physician or an immediate family member.

Catalyst Orthoscience$35K

What the payments were for

Consulting fees$40,24240%
Travel & lodging$10,35610%
Food & beverage$13,63514%
Education$36,23536%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Catalyst Orthoscience	37	$35,129
Skeletal Dynamics Inc	26	$28,931
Zimmer Biomet	117	$20,663
Shoulder Innovations, Inc.	6	$4,196
Stryker(2 entities)	29	$3,985
Biedermann Motech, Inc.	5	$3,354
Lima USA, Inc.	3	$2,930
Exactech, Inc.	3	$419
Prodigy Surgical Distribution, Inc.	2	$286
Smith+Nephew	3	$237
Johnson & Johnson	5	$148
Vertex	2	$43
Boston Scientific	1	$36
Axogen	1	$34
Amgen	2	$28
Globus Medical	1	$27
Heraeus Medical, LLC.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

IJS$28,451
Geminus$28,330
Align$28,330
Implate$28,210
Catalyst Total CSR$14,976
Archer CSR Total Shoulder System$12,915
Archer R1 Reverse Shoulder System$12,915
ALLIANCE$10,875
Catalyst CSR Shoulder System$5,012
InSet System$4,196
SMR$2,930
Comprehensive Shoulder System$2,771
Proximal Humerus Plating System$2,706
Midshaft Plating System$2,148
Olecranon Plating System$1,706
BLUEPRINT PSI SYSTEM$1,512
BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$1,237
Catalyst TSR$900
COMPREHENSIVE$852
CSR & R1 Reverse Total Shoulder Systems$443

How this compares

$100,469 in reported general payments places this provider in the 85th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$194,663

Medicare patients

525

Services billed

1,979

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	61	$552
Mupirocin	56	$435
Methylprednisolone	46	$394
Cyclobenzaprine Hcl	27	$153
Ibuprofen	17	$80
Oxycodone Hcl	13	$71
Amoxicillin	27	$59
Meloxicam	11	$44

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Albany

Andrew RosenbaumAlbany$467K
Anthony RomeoNew York$26.8M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$13.2M
William RicciNew York$11.6M
Steven HaasNew York$11.3M
Giles ScuderiNew York$10.7M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →